The decisive midterm elections will have significant implications for a wide range of health policy priorities—in Congress, ...
The answer lies in a powerful narrative circulating for years before the FDA convened its panel, one that recast the original ...
Advocates for Head Start are faced with the question of whether the program can remain as effective without the same ...
Rachel Sachs breaks down a final rule from CMS establishing the framework for the Medicare Drug Price Negotiation Program in 2029 and evaluates how the Trump administration's broader drug pricing ...
Nearly two-thirds of respondents in a Cornell Health Policy Insight Panel survey said HR 1 implementation could cause states to scale back Medicaid expansions; a majority said the law’s limits on ...
As the US population ages, the current epidemic of overly mechanized deaths threatens to explode into a major public health, and fiscal, crisis. Our aging population is at risk from a most ...
Despite lower negotiated prices, uncertainty around GLP-1 uptake, budget exposure, and long-term cost offsets may limit state participation in BALANCE.
Local communities expect H.R. 1 and subsequent Centers for Medicare and Medicaid Services rules to place financial strain on a system already struggling with inadequate reimbursement. In most ...
The Patient Protection and Affordable Care Act establishes a national voluntary program for accountable care organizations (ACOs) by January 2012 under the auspices of the Centers for Medicare and ...
While not without challenges, payment reform is the only obvious market solution to persistent nurse turnover and understaffing, both of which are harmful to patients and costly for hospitals and ...
Exhibit 1 National health expenditures (NHE) and personal health care (PHC) expenditures, aggregate and per capita amounts, share of gross domestic product (GDP), and annual growth, selected calendar ...